| Date Filed | Type | Description |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/13/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/13/2022 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 61.3% stake in VYCOR MEDICAL, INC. |
| 04/13/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/01/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/08/2021 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 59.2% stake in VYCOR MEDICAL, INC. |
| 08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 07/20/2021 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 58.5% stake in VYCOR MEDICAL, INC. |
| 05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/22/2021 |
8-K
| Quarterly results |
| 01/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/13/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 10/06/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 08/17/2020 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/07/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/30/2020 |
8-K
| Quarterly results |
| 05/12/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 04/07/2020 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 59.1% stake in VYCOR MEDICAL, INC. |
| 03/27/2020 |
8-K
| Quarterly results |
| 03/27/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 01/07/2020 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 58.2% stake in VYCOR MEDICAL, INC. |
| 11/12/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 10/09/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|